ALPS Advisors’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,557
Closed -$113K 997
2023
Q3
$113K Buy
3,557
+194
+6% +$6.16K ﹤0.01% 969
2023
Q2
$277K Buy
3,363
+516
+18% +$42.4K ﹤0.01% 918
2023
Q1
$293K Buy
2,847
+138
+5% +$14.2K ﹤0.01% 904
2022
Q4
$397K Buy
+2,709
New +$397K ﹤0.01% 680